FACTANKER

US-Listed Pharmaceutical Preparations — EBITDA Margin Percentiles, FY 2024

Population: 150 US-listed companies (SIC 2834), fiscal year 2024; fiscal year ends 2024-06-30 to 2025-05-25.

Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest

10th percentile-573.6%
25th percentile-264.3%
Median-48.2%
75th percentile2.3%
90th percentile19.8%
Mean-173.1%
Minimum-993.0%
Maximum58.4%
Methodology & sources
EBITDA margin = (operating income + depreciation & amortization) / revenue, all values as filed; computed in SQL per company, then percentiles. Fiscal year 2024 = fiscal years ending 2024-06-01 to 2025-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-03.

Evidence samples

Latest EBITDA Margin percentiles (live) · All Pharmaceutical Preparations benchmarks · All industries

Cite as: FACTANKER, https://factanker.com/industries/sic-2834/ebitda-margin/2024